Jordan's Hikma Pharmaceuticals has made its first foray into Morocco with a $111 million deal for controlling interest in Promopharm, the country's 9th-largest drugmaker with 200 branded generics and in-licensed products. The company plans to introduce about 20 Hikma products into the market as well. Report